SCHEMBL3454152

SCHEMBL3454152

Cc1nc(C#Cc2cc[c]cc2)sc1C(=O)NCc1ccc(Cl)cc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 4/20 0.51
PPARD Q03181 1/20 0.51
CHRM4 P08173 3/20 0.48
GAA P10253 1/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
LMNA P02545 3/20 0.46
ALDH1A1 P00352 1/20 0.46
TSHR P16473 1/20 0.46
TP53 P04637 3/20 0.43
THRB P10828 1/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
GALR3 O60755 1/20 0.42
NR2F2 P24468 1/20 0.42
RAB9A P51151 1/20 0.42
SCD O00767 1/20 0.42
HPGD P15428 1/20 0.42
MAPT P10636 3/20 0.41
RXFP1 Q9HBX9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3455202 0.84 PPARA (0.55) PPARAPPARDCHRM4GAASMN1; SMN2
SCHEMBL3454459 0.77 SCD (0.55) PPARAPPARDCHRM4SMN1; SMN2LMNA
SCHEMBL3454348 0.77 SCD (0.55) SCD
SCHEMBL3455026 0.77 PPARA (0.55) PPARAPPARDCHRM4GAASMN1; SMN2
SCHEMBL3454860 0.76 MAOB (0.52) LMNAALDH1A1THRBKMT2AMEN1
SCHEMBL3468898 0.76 PPARA (0.52) PPARAPPARDCHRM4SMN1; SMN2LMNA
SCHEMBL3575995 0.76 CHRM4 (0.61) PPARAPPARDCHRM4GAASMN1; SMN2
SCHEMBL3455092 0.76 PPARD (0.56) PPARAPPARDCHRM4GAASMN1; SMN2
SCHEMBL3454756 0.75 LMNA (0.45) PPARAPPARDCHRM4GAASMN1; SMN2
SCHEMBL13541938 0.75 PPARA (0.48) PPARAPPARDCHRM4GAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010007482-A2 THIAZOLE DERIVATIVES AS STEAROYL COA DESATURASE INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2010-01-21 WO disclosed